Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Biomarkers
Treatment
Clinical Care
Prevention
View all Topics
Conferences
AAIC 2023
BNA 2023
AD/PD 2023
ARUK 2023
CTAD 2022
AAIC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Perspectives
2:53
Roadblocks to the use of blood-based biomarkers in clinical care
Suzanne Schindler
• 19 Jul 2023
1:08
Why Alzheimer’s disease research is focusing on tau
Sonya Miller
• 17 Jul 2023
1:35
Barriers to participation of underrepresented groups in clinical trials
Doris Molina-Henry
• 18 Jul 2023
4:15
How social media is shaping public opinion on scientific research
Kent Hendrix
• 19 Jul 2023
5:22
Understanding the global burden of dementia: challenges and opportunities
Monica Diaz
• 2 May 2023
2:59
Studying the proteome in Alzheimer’s Disease
Betty Tijms
• 27 Mar 2023
1:36
NE3107 properties and mode of action
Joseph Michael Palumbo
• 26 Apr 2023
2:28
Ongoing concerns regarding lecanemab: efficacy & adverse events
Philip Tipton
• 27 Apr 2023
4:08
The future of focused ultrasound in AD
Philip Tipton
• 27 Apr 2023
3:45
Prioritizing research on neuromodulatory subcortical systems for new insights in Alzheimer’s disease
Alexander J. Ehrenberg
• 16 Mar 2023
2:05
Random forests in large-scale omics studies
Betty Tijms
• 27 Mar 2023
2:34
Assessing clinical meaningfulness with ‘time saved’ in Alzheimer’s disease
Suzanne Hendrix
• 21 Mar 2023
1:32
Targeting the immune system in Alzheimer’s disease
Emma Mead
• 24 Apr 2023
2:21
How feasible is an Alzheimer’s disease blood test in the UK?
Amanda Heslegrave
• 10 Mar 2023
1:21
TREM2 as a target for disease modification in Alzheimer’s disease
Elina Svensson
• 6 Apr 2023
2:26
Why have anti-amyloid monoclonal antibodies performed differently in Phase III trials
Stephen Salloway
• 19 Apr 2023
1
2
3
4
5
…
11
Next